Short Interest in Dominari Holdings Inc. (NASDAQ:DOMH) Increases By 396.4%

Dominari Holdings Inc. (NASDAQ:DOMH) was the target of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 41,200 shares, an increase of 396.4% from the December 31st total of 8,300 shares. Approximately 1.2% of the shares of the company are short sold. Based on an average daily trading volume, of 27,200 shares, the short-interest ratio is presently 1.5 days.

Dominari Stock Performance

Shares of Dominari stock remained flat at $2.00 during trading on Tuesday. The stock had a trading volume of 274,577 shares, compared to its average volume of 129,075. Dominari has a twelve month low of $0.83 and a twelve month high of $3.20. The company has a market cap of $12.68 million, a price-to-earnings ratio of -0.52 and a beta of 1.03. The stock has a 50 day moving average price of $1.40 and a two-hundred day moving average price of $1.63.

Dominari (NASDAQ:DOMH) last issued its quarterly earnings results on Friday, November 8th. The company reported ($0.45) EPS for the quarter. Dominari had a negative return on equity of 32.89% and a negative net margin of 180.22%. The business had revenue of $4.04 million during the quarter.

Dominari Company Profile

Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.